After acquiring 23andMe, Regeneron Pharmaceuticals has said it will protect user data as it uses DNA data for drug development.

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.

The top bidder in the DNA testing firm's bankruptcy auction, Regeneron vows to prioritize the privacy, security, and ethical use of customer data.

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.

Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles including a data breach.

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, promising to honor existing privacy protections and continue consumer services with no changes.

RALEIGH, NC (WWAY) — North Carolinians have until July 14th, to file claims against DNA testing company 23andMe for any general claims against the company or claims related to the cyber security incident reported in 2023. Attorney General Jeff Jackson ...